ZyVersa Therapeutics Research and Development Expenses 2022-2024 | ZVSA

ZyVersa Therapeutics research and development expenses from 2022 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Historical Chart (TTM)

Click on chart icon to view chart
Click on table icon to view table

Quarterly

Click on chart icon to view chart
Click on table icon to view table

Quarterly - YOY Change

Click on chart icon to view chart
Click on table icon to view table

Annual

Click on chart icon to view chart
Click on table icon to view table

Annual % Change

Click on chart icon to view chart
Click on table icon to view table